e.almeida
TL2 Member · Haarlem, NL
Based in the EU. Tracks what is available and funded locally, and dates every claim.
Joined 20 September 2024 · last posted 10d · groups: regional-eu
95 posts, newest first. Showing up to 150.
-
What a good consultation looks like from the other side Replied, post #60 · Clinical › Prescriber conversations · 18 Jul 2026 · 0 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
Journal club: what we got wrong in an earlier session Replied, post #89 · Evidence › Journal club · 16 Jul 2026 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #87 · Practice › Storage & stability · 13 Jul 2026 · 0 likes This follows post #84 rather than contradicting it. I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is…
-
Official shortage notices and what they authorise Replied, post #120 · Access › Shortages · 21 Jun 2026 · 13 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2026 · 1 like Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Naming conventions for research peptides and the confusion they cause Replied, post #17 · Compounds › Other compounds · 18 Jun 2026 · 1 like Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #3 · Evidence › Preprints · 17 Jun 2026 · 10 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #50 · Analytics › Method validation · 11 Jun 2026 · 23 likes I read post #48 twice before replying, because I had assumed the opposite. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #121 · Practice › Interactions · 7 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #42 · Sourcing › Red flags · 4 Jun 2026 · 1 like Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #43 · Compounds › Semaglutide · 29 May 2026 · 21 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #25 · Pharmacology › Formulation chemistry · 23 May 2026 · 0 likes Container closure: the vial material, rubber closure, and sealing all affect permeability to water and oxygen. Glass is less permeable than plastic. Rubber quality…
-
Spreadsheets: an appreciation — what changed since Replied, post #44 · Lounge › Off topic · 16 May 2026 · 0 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
An 18-month record including the parts that went badly Replied, post #16 · Outcomes › Progress reports · 14 May 2026 · 3 likes I read post #14 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Blind submission and why it changes minds — the long version Replied, post #53 · Sourcing › Independent verification · 2 May 2026 · 19 likes Worth separating two things that post #49 runs together. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #36 · Practice › Interactions · 2 May 2026 · 10 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #4 · Analytics › COA interpretation · 27 Apr 2026 · 7 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
[2026 update] What a purity-only report leaves out Replied, post #97 · Sourcing › Independent verification · 20 Apr 2026 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #11 · Devices › Syringes & needles · 9 Apr 2026 · 11 likes Picking up post #8: that is the part I would want checked first. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02…
-
Grapefruit: why this class is not the class that cares Replied, post #123 · Practice › Interactions · 5 Apr 2026 · 13 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Second pass at: Submitting a sample: the process end to end Replied, post #16 · Sourcing › Independent verification · 26 Mar 2026 · 1 like On post #12 — agreed on the reasoning, with one qualification. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #51 · Data & Tools › Calculators · 19 Mar 2026 · 15 likes On post #47 — agreed on the reasoning, with one qualification. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #55 · Start Here › Welcome · 19 Mar 2026 · 10 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Started this topic · Clinical › Comorbidities · 15 Mar 2026 · 8 likes Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #48 · Research Methods › Statistics · 8 Mar 2026 · 0 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #17 · Compounds › Secretagogues & GH axis · 3 Mar 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #145 · Sourcing › Independent verification · 2 Mar 2026 · 23 likes post #144 is right about the mechanism and I think understates the practical bit. How to submit a sample: contact the service directly. They will provide instructions…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #95 · Evidence › Study critique · 28 Feb 2026 · 0 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Clearance pathways and what renal impairment changes Replied, post #9 · Pharmacology › Pharmacokinetics · 24 Feb 2026 · 7 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Research-use-only labelling: what it means and what it does not Replied, post #107 · Sourcing › Regulatory · 23 Feb 2026 · 0 likes Coming back to post #105, because the follow-up matters more than the original answer. Preclinical versus clinical: compounds with strong preclinical data can fail in…
-
Choosing which test to pay for, given a fixed budget Replied, post #2 · Sourcing › Independent verification · 20 Feb 2026 · 8 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #35 · Practice › Storage & stability · 7 Feb 2026 · 5 likes Coming back to post #33, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Dead volume across syringe and needle combinations Replied, post #61 · Devices › Syringes & needles · 26 Jan 2026 · 2 likes post #60 is right about the mechanism and I think understates the practical bit. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #80 · Clinical › Special populations · 25 Jan 2026 · 8 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Journal club: PIONEER 6 as a safety trial Replied, post #13 · Evidence › Journal club · 6 Jan 2026 · 11 likes On post #9 — agreed on the reasoning, with one qualification. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
-
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #3 · Compounds › Repair & healing peptides · 2 Jan 2026 · 21 likes I read the opening post twice before replying, because I had assumed the opposite. Reading a preclinical wound-healing model: the model shows whether a mechanism is…
-
What to include when your question involves a chromatogram Replied, post #12 · Start Here › How to Ask · 31 Dec 2025 · 1 like On post #8 — agreed on the reasoning, with one qualification. The specific question in the title is more useful than you might think. A title like "a question I have"…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #38 · Compounds › Other compounds · 27 Dec 2025 · 24 likes Picking up post #35: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #33 · Compounds › Retatrutide · 25 Dec 2025 · 9 likes This follows post #30 rather than contradicting it. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #24 · Practice › Side effects · 12 Dec 2025 · 0 likes post #23 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #59 · Compounds › Semaglutide · 1 Dec 2025 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Reading an interaction checker output critically Replied, post #44 · Practice › Interactions · 16 Nov 2025 · 0 likes On post #40 — agreed on the reasoning, with one qualification. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be…
-
New subcategory: rationale and scope Replied, post #115 · Meta › Announcements · 25 Oct 2025 · 15 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #19 · Start Here › How to Ask · 23 Oct 2025 · 0 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #46 · Compounds › Tirzepatide · 21 Oct 2025 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #116 · Practice › Administration · 18 Oct 2025 · 28 likes Picking up post #113: that is the part I would want checked first. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always…
-
A preprint whose numbers changed substantially at publication Replied, post #51 · Evidence › Preprints · 13 Sep 2025 · 5 likes Picking up post #48: that is the part I would want checked first. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data,…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #79 · Data & Tools › Datasets · 9 Sep 2025 · 1 like Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
-
Research-use-only labelling: what it means and what it does not Replied, post #30 · Sourcing › Regulatory · 5 Sep 2025 · 0 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
When to stop reading forums, including this one Replied, post #22 · Wellbeing › Mental health · 5 Sep 2025 · 5 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Temperature loggers worth the money Replied, post #25 · Devices › Cold chain · 2 Sep 2025 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #109 · Compounds › Tirzepatide · 20 Aug 2025 · 11 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
An emergency department visit, described afterwards Replied, post #56 · Safety › Adverse events · 20 Aug 2025 · 0 likes Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel obstruction warrant urgent evaluation. Mild nausea and…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #10 · Data & Tools › Datasets · 14 Aug 2025 · 22 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #46 · Compounds › Retatrutide · 13 Aug 2025 · 0 likes On post #42 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #6 · Evidence › Journal club · 9 Aug 2025 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
"Should I double up?" — answered once, at length, calmly Replied, post #10 · Practice › Administration · 4 Aug 2025 · 6 likes This follows post #7 rather than contradicting it. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a…
-
How to research a compound with no human data without deceiving yourself Replied, post #71 · Compounds › Other compounds · 2 Aug 2025 · 14 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #27 · Practice › Reconstitution · 18 Jul 2025 · 14 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
A field-by-field walk through a certificate of analysis Replied, post #61 · Analytics › COA interpretation · 16 Jul 2025 · 13 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #157 · Evidence › Journal club · 12 Jul 2025 · 14 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #47 · Compounds › Cagrilintide & amylin analogues · 11 Jul 2025 · 6 likes Picking up post #44: that is the part I would want checked first. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms.…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #22 · Data & Tools › Datasets · 2 Jul 2025 · 0 likes On post #18 — agreed on the reasoning, with one qualification. Combining data from different sources: datasets from this site are not directly comparable to published…
-
Comparing my trajectory with the trial curves, carefully Replied, post #12 · Outcomes › Progress reports · 8 Jun 2025 · 0 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #42 · Regional › UK & Ireland · 2 Jun 2025 · 0 likes Picking up post #39: that is the part I would want checked first. Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only.…
-
Antibiotics and a course of something with delayed emptying Replied, post #38 · Practice › Interactions · 10 May 2025 · 1 like Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Adjudicated events and why the definition matters — the long version Replied, post #115 · Evidence › Trials · 23 Apr 2025 · 6 likes Coming back to post #113, because the follow-up matters more than the original answer. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the…
-
Requesting a page: what makes a good request Replied, post #56 · Documentation › Wiki requests · 13 Apr 2025 · 24 likes Worth separating two things that post #52 runs together. Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues,…
-
A certificate with no method stated: what can you conclude? Replied, post #48 · Analytics › COA interpretation · 9 Apr 2025 · 24 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Preservatives: function, testing, and limits Replied, post #27 · Pharmacology › Formulation chemistry · 2 Apr 2025 · 0 likes Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised formulations protect the peptide during drying and storage. They are not impurities;…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #78 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 0 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
A certificate with no method stated: what can you conclude? Replied, post #9 · Analytics › COA interpretation · 30 Mar 2025 · 11 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Assessing a warm arrival: the decision process Replied, post #18 · Sourcing › Logistics · 24 Mar 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Maintainer handover: how it works Replied, post #57 · Meta › Wiki maintenance · 17 Mar 2025 · 24 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #103 · Pharmacology › Receptor biology · 15 Mar 2025 · 1 like I read post #101 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #82 · Analytics › COA interpretation · 14 Mar 2025 · 11 likes Coming back to post #80, because the follow-up matters more than the original answer. When a document puts the specification in the result column, it has told you the…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #27 · Practice › Interactions · 6 Mar 2025 · 5 likes Coming back to post #25, because the follow-up matters more than the original answer. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A,…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #69 · Compounds › Secretagogues & GH axis · 4 Feb 2025 · 27 likes post #68 is right about the mechanism and I think understates the practical bit. GHRH analogues versus ghrelin mimetics are often conflated but they are different…
-
Canadian access and provincial variation Replied, post #48 · Regional › North America · 3 Feb 2025 · 19 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #95 · Compounds › Semaglutide · 29 Jan 2025 · 6 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
A page that has drifted out of date and needs a maintainer Replied, post #47 · Documentation › Wiki requests · 3 Jan 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #17 · Practice › Dosing & titration · 16 Dec 2024 · 30 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Transit times by route, from a logged dataset — the long version Replied, post #38 · Sourcing › Logistics · 12 Dec 2024 · 3 likes Picking up post #35: that is the part I would want checked first. Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #11 · Evidence › Journal club · 9 Dec 2024 · 1 like This follows post #8 rather than contradicting it. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #3 · Practice › Reconstitution · 1 Nov 2024 · 7 likes I read the opening post twice before replying, because I had assumed the opposite. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #17 · Clinical › Comorbidities · 11 Oct 2024 · 6 likes On post #13 — agreed on the reasoning, with one qualification. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral…
-
Gallbladder disease risk with rapid weight loss Replied, post #15 · Clinical › Comorbidities · 2 Oct 2024 · 3 likes I read post #13 twice before replying, because I had assumed the opposite. Interactions between comorbidities: diabetes and kidney disease together change the risk…
-
Correlation in a self-tracked dataset: what it can support Replied, post #52 · Research Methods › Statistics · 22 Aug 2024 · 2 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #15 · Analytics › Method validation · 13 Aug 2024 · 0 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #16 · Analytics › COA interpretation · 8 Aug 2024 · 9 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
How this community labels and discusses unrefereed work Replied, post #93 · Evidence › Preprints · 18 Jul 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #8 · Compounds › Retatrutide · 15 Jul 2024 · 0 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #5 · Analytics › COA interpretation · 13 Jul 2024 · 18 likes Worth separating two things that the opening post runs together. What fields matter on a certificate: lot number matching the vial, test date, the analytical method…
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #4 · Practice › Administration · 1 Jul 2024 · 31 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Started this topic · Analytics › Method validation · 14 Jun 2024 · 0 likes Relative retention time as a better inter-laboratory comparator — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context…